Assignee
PTC THERAPEUTICS INC
US·126 granted patents·79 pending applications·1,260 citations·filing 1999–2025
Top patents by PatentIndex Score
205 records- 0199US7772259B21,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2005·Granted Aug 10, 2010·83 cites·33 claims
- 0299US7419991B23-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereofPTC THERAPEUTICS INC·Filed 2006·Granted Sep 2, 2008·70 cites·24 claims
- 0399US7304080B2Substituted 1,2,4-oxadiazoles, compositions and methods of usePTC THERAPEUTICS INC·Filed 2006·Granted Dec 4, 2007·55 cites·19 claims
- 0499US7202262B2Benzoic acid or benzoate substituted 1,2,4-oxadiazole compounds and their use for the treatment of diseasePTC THERAPEUTICS INC·Filed 2005·Granted Apr 10, 2007·111 cites·19 claims
- 0599US6992096B21,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2004·Granted Jan 31, 2006·190 cites·7 claims
- 0698US8796322B2Methods for using 1,2,4-oxadiazole benzoic acid compoundsPTC THERAPEUTICS INC·Filed 2013·Granted Aug 5, 2014·21 cites·20 claims
- 0798US8017636B21,2,4-Oxadiazole benzoic acid compositions and their use in bioassaysPTC THERAPEUTICS INC·Filed 2010·Granted Sep 13, 2011·23 cites·4 claims
- 0898US7683082B21,2,4-oxadiazole benzoic acid compositions and their use in bioassaysPTC THERAPEUTICS INC·Filed 2007·Granted Mar 23, 2010·28 cites·4 claims
- 0997US9205088B2Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their usePTC THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·13 cites·21 claims
- 1097US8975287B2Methods for using 1,2,4-Oxadiazole benzoic acid compoundsPTC THERAPEUTICS INC·Filed 2014·Granted Mar 10, 2015·12 cites·16 claims
- 1196US7863456B2Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acidPTC THERAPEUTICS INC·Filed 2007·Granted Jan 4, 2011·29 cites·9 claims
- 1296US7767689B2Carboline derivatives useful in the treatment of cancerPTC THERAPEUTICS INC·Filed 2005·Granted Aug 3, 2010·40 cites·12 claims
- 1395US10071081B2Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their usePTC THERAPEUTICS INC·Filed 2017·Granted Sep 11, 2018·5 cites·18 claims
- 1495US9879007B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2016·Granted Jan 30, 2018·18 cites·4 claims
- 1595US9873677B2Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acidPTC THERAPEUTICS INC·Filed 2015·Granted Jan 23, 2018·8 cites·21 claims
- 1695US9371336B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Jun 21, 2016·36 cites·5 claims
- 1795US7601840B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2005·Granted Oct 13, 2009·39 cites·7 claims
- 1894US9861617B2Compositions of 1,2,4-oxadiazole benzoic acid compounds and methods for their usePTC THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·4 cites·21 claims
- 1994US9617268B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2012·Granted Apr 11, 2017·32 cites·5 claims
- 2094US9586955B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Mar 7, 2017·22 cites·21 claims
- 2194US7678922B2Processes for the preparation of 1,2,4-oxadiazole benzoic acidsPTC THERAPEUTICS INC·Filed 2007·Granted Mar 16, 2010·31 cites·15 claims
- 2294US7405233B2Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of diseasePTC THERAPEUTICS INC·Filed 2005·Granted Jul 29, 2008·27 cites·2 claims
- 2393US11304914B2Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2020·Granted Apr 19, 2022·2 cites·26 claims
- 2493US9399649B2Compounds for treating spinal muscular atrophyPTC THERAPEUTICS INC·Filed 2013·Granted Jul 26, 2016·34 cites·11 claims
- 2593US7868037B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2006·Granted Jan 11, 2011·18 cites·31 claims
- 2692US11174212B22,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Nov 16, 2021·5 cites·32 claims
- 2792US9309206B2Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4] oxadiazol-3-yl]-benzoic acidPTC THERAPEUTICS INC·Filed 2014·Granted Apr 12, 2016·9 cites·11 claims
- 2891US11186559B2Methods for enriching alpha-tocotrienol from mixed tocol compositionsPTC THERAPEUTICS INC·Filed 2020·Granted Nov 30, 2021·3 cites·23 claims
- 2991US10874672B2Methods for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2016·Granted Dec 29, 2020·13 cites·28 claims
- 3091US10703701B2Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2016·Granted Jul 7, 2020·7 cites·23 claims
- 3191US9522137B2Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2015·Granted Dec 20, 2016·8 cites·10 claims
- 3290US9877952B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2017·Granted Jan 30, 2018·6 cites·9 claims
- 3390US9737513B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapyPTC THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·6 cites·9 claims
- 3490US7781478B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2007·Granted Aug 24, 2010·8 cites·7 claims
- 3589US11390588B22-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereofPTC THERAPEUTICS INC·Filed 2020·Granted Jul 19, 2022·2 cites·15 claims
- 3689US10981855B2Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2020·Granted Apr 20, 2021·2 cites·18 claims
- 3789US10517853B2Methods for treating epilepsyPTC THERAPEUTICS INC·Filed 2016·Granted Dec 31, 2019·9 cites·8 claims
- 3889US10034863B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·5 cites·8 claims
- 3989US9474743B2Compositions for an orally active 1,2,4-oxadiazole for the treatment of diseasePTC THERAPEUTICS INC·Filed 2014·Granted Oct 25, 2016·8 cites·15 claims
- 4089US9394539B1Survival motor neuron gene (SMN2) mRNA constructs for post-transcription regulationPTC THERAPEUTICS INC·Filed 2012·Granted Jul 19, 2016·14 cites·20 claims
- 4189US8372860B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2010·Granted Feb 12, 2013·12 cites·21 claims
- 4289US8367694B2Carboline derivatives useful in the inhibition of angiogenesisPTC THERAPEUTICS INC·Filed 2009·Granted Feb 5, 2013·12 cites·23 claims
- 4389US7772271B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2007·Granted Aug 10, 2010·8 cites·7 claims
- 4488US11667596B22,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·1 cites·19 claims
- 4588US10751302B2Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamidePTC THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·2 cites·20 claims
- 4688US10172836B2Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapyPTC THERAPEUTICS INC·Filed 2018·Granted Jan 8, 2019·4 cites·9 claims
- 4788US8367841B2Processes for the preparation of 1,2,4-oxadiazole benzoic acidsPTC THERAPEUTICS INC·Filed 2009·Granted Feb 5, 2013·10 cites·8 claims
- 4888US7645881B2Methods for treating hepatitis CPTC THERAPEUTICS INC·Filed 2005·Granted Jan 12, 2010·5 cites·12 claims
- 4987US10195202B2Methods for modulating the amount of RNA transcriptsPTC THERAPEUTICS INC·Filed 2014·Granted Feb 5, 2019·4 cites·8 claims
- 5087US10028939B2Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid for the treatment of diseasePTC THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·3 cites·18 claims
Showing the top 50 of 205 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →